Search results
Why Roche Holdings Stock Popped Today
Motley Fool via Yahoo Finance· 2 months agoShares of Swiss pharmaceuticals giant Roche Holdings (OTC: RHHBY) stock popped 2.5% in early trading Thursday before giving back about half of its gains....
Are Roche Holding AG's (VTX:ROG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent...
Simply Wall St. via Yahoo Finance· 8 months agoRoche Holding (VTX:ROG) has had a rough three months with its share price down 8.6%. However, stock...
Declining Stock and Decent Financials: Is The Market Wrong About Roche Holding AG (VTX:ROG)?
Simply Wall St. via Yahoo Finance· 1 year agoRoche Holding (VTX:ROG) has had a rough three months with its share price down 5.9%. However, stock...
Why Roche's Accidental Cancer Update Boosted Several Rivals By As Much As 22%
Investor's Business Daily· 9 months agoRoche accidentally published positive interim results from a lung cancer treatment study on...
Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the FDA approved intravenously-administered Lunsumio (mosunetuzumab) for...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Roche (RHHBY) & Lilly to Co-Develop Alzheimer's Detection Device
Zacks via Yahoo Finance· 1 year agoRoche Holding AG RHHBY announced a collaboration with Eli Lilly and Company LLY where the latter...
Roche's (RHHBY) Evrysdi Gets Label Expansion in EU for Newborns
Zacks via Yahoo Finance· 9 months agoRoche RHHBY announced that the European Commission (“EC”) had approved the label expansion for...
Biogen Soars On Upgrade; Why Lilly, Roche Won't Block Its Alzheimer's Opportunity
Investor's Business Daily· 2 years agoBiogen could easily take on Roche and Eli Lilly in Alzheimer's treatment, an analyst said Thursday...
Roche's (RHHBY) Lunsumio Application Gets Priority Review
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) BLA application seeking approval for the use of Lunsumio for relapsed or refractory...